Department of Anesthesiology, Perioperative and Pain Medicine
Stanford University School of Medicine
California
Stanford University School of Medicine
California
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a class of oral diabetes medications that have multiple indications and benefits for patients with heart failure and chronic kidney disease. These medications can lead to euglycemic diabetic ketoacidosis (eDKA) and euglycemic ketoacidosis, which are rare but potentially